RAPT Therapeutics Inc. (RAPT)
NASDAQ: RAPT
· Real-Time Price · USD
11.36
0.11 (0.98%)
At close: Aug 15, 2025, 1:24 PM
0.98% (1D)
| Bid | 11.35 |
| Market Cap | 187.87M |
| Revenue (ttm) | n/a |
| Net Income (ttm) | -106.49M |
| EPS (ttm) | -14.8 |
| PE Ratio (ttm) | -0.77 |
| Forward PE | -3.02 |
| Analyst | Hold |
| Ask | 11.5 |
| Volume | 149,528 |
| Avg. Volume (20D) | 136,382.9 |
| Open | 11.38 |
| Previous Close | 11.25 |
| Day's Range | 11.00 - 11.66 |
| 52-Week Range | 5.66 - 26.56 |
| Beta | 0.01 |
About RAPT
undefined
Industry n/a
Sector n/a
IPO Date n/a
Employees NaN
Stock Exchange n/a
Ticker Symbol RAPT
Website n/a
Analyst Forecast
According to 0 analyst ratings, the average rating for RAPT stock is "n/a." The 12-month stock price forecast is $n/a, which is a decrease of 0% from the latest price.
Stock Forecasts7 months ago
+110.91%
RAPT Therapeutics shares are trading higher after ...
Unlock content with
Pro Subscription
9 months ago
-39.45%
RAPT Therapeutics shares are trading lower after the company terminated its Zelnecirnon program following an FDA clinical hold due to a severe adverse event involving liver injury.
